New Review Describes Use of AOPs in EPA Screening Program

Home / Community Blog / New Review Describes Use of AOPs in EPA Screening Program

Community Blog

New Review Describes Use of AOPs in EPA Screening Program

A review in the September issue of the journal Environmental Health Perspectives describes how the U.S. Environmental Protection Agency (EPA) uses adverse outcome pathway (AOP) and toxicity pathway frameworks in its Endocrine Disruptor Screening Program. The review describes how these frameworks help to establish biologically plausible links between endocrine mechanisms and apical responses when those end points are not measured in the same assay.

Catherine Sprankle
Catherine Sprankle
Communications Specialist for NICEATM

Leave a Comment

*